Bortezomib 68083-0650-01
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 6, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219167
Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bortezomib | 1 mg/1 |
Drug Class
Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]
Selected Package
68083-0650-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (68083-650-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE